MEDX
MEDX
Horizon Kinetics Medical ETF • Horizon Kinetics
$33.68 ▲ 0.40% (+0.13)
Managing Company Horizon Kinetics
Asset Under Management $19.20M
Inception Date Jan 26, 2023
Expense Ratio 0.85%
52w High $34.29
52w Low $23.46
Volume 50
Avg Volume 827
Asset Class Equity
About Horizon Kinetics Medical ETF
The Horizon Kinetics Medical ETF seeks long-term growth of capital by investing primarily in patented first line pharmaceuticals and biologics.
Managing Company Horizon Kinetics
Asset Under Management $19.20M
Inception Date Jan 26, 2023
Expense Ratio 0.85%
52w High $34.29
52w Low $23.46
Volume 50
Avg Volume 827
Asset Class Equity
About Horizon Kinetics Medical ETF
The Horizon Kinetics Medical ETF seeks long-term growth of capital by investing primarily in patented first line pharmaceuticals and biologics.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 LLY | Eli Lilly and Company | 18.23% | 3.22K | $3.57M |
 ABBV | AbbVie Inc. | 8.78% | 7.36K | $1.72M |
 NVS | Novartis AG | 6.68% | 9.19K | $1.31M |
 AZN | AstraZeneca PLC | 5.35% | 10.99K | $1.05M |
 ALNY | Alnylam Pharmaceuticals, Inc. | 5.13% | 2.38K | $1.00M |
 IONS | Ionis Pharmaceuticals, Inc. | 5.08% | 11.95K | $994.05K |
 JNJ | Johnson & Johnson | 4.88% | 4.60K | $954.87K |
 BMY | Bristol-Myers Squibb Company | 4.66% | 16.05K | $910.47K |
 AMGN | Amgen Inc. | 3.95% | 2.26K | $772.11K |
 MRK | Merck & Co., Inc. | 3.57% | 6.44K | $698.95K |
 ALKS | Alkermes plc | 3.31% | 22.07K | $647.86K |
 PFE | Pfizer Inc. | 3.21% | 24.82K | $627.55K |
 CRSP | CRISPR Therapeutics AG | 3.00% | 10.11K | $586.51K |
 REGN | Regeneron Pharmaceuticals, Inc. | 2.87% | 690 | $560.47K |
 BIIB | Biogen Inc. | 2.86% | 2.99K | $558.49K |
 GSK | GSK plc | 2.79% | 10.79K | $546.29K |
 BEAM | Beam Therapeutics Inc. | 1.36% | 9.19K | $265.98K |
 VNDA | Vanda Pharmaceuticals Inc. | 1.08% | 24.82K | $212.00K |
 GALT | Galectin Therapeutics Inc. | 0.93% | 51.48K | $182.25K |
 NTLA | Intellia Therapeutics, Inc. | 0.71% | 13.79K | $139.71K |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
Switzerland
United Kingdom Other
7.52%
IrelandSECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States Switzerland United Kingdom Other
7.52% IrelandHoldings (Top 20)
LLY
Eli Lilly and Company
Weight: 18.23% Shares: 3.22K Value: $3.57M
ABBV
AbbVie Inc.
Weight: 8.78% Shares: 7.36K Value: $1.72M
NVS
Novartis AG
Weight: 6.68% Shares: 9.19K Value: $1.31M
AZN
AstraZeneca PLC
Weight: 5.35% Shares: 10.99K Value: $1.05M
ALNY
Alnylam Pharmaceuticals, Inc.
Weight: 5.13% Shares: 2.38K Value: $1.00M
IONS
Ionis Pharmaceuticals, Inc.
Weight: 5.08% Shares: 11.95K Value: $994.05K
JNJ
Johnson & Johnson
Weight: 4.88% Shares: 4.60K Value: $954.87K
BMY
Bristol-Myers Squibb Company
Weight: 4.66% Shares: 16.05K Value: $910.47K
AMGN
Amgen Inc.
Weight: 3.95% Shares: 2.26K Value: $772.11K
MRK
Merck & Co., Inc.
Weight: 3.57% Shares: 6.44K Value: $698.95K
ALKS
Alkermes plc
Weight: 3.31% Shares: 22.07K Value: $647.86K
PFE
Pfizer Inc.
Weight: 3.21% Shares: 24.82K Value: $627.55K
CRSP
CRISPR Therapeutics AG
Weight: 3.00% Shares: 10.11K Value: $586.51K
REGN
Regeneron Pharmaceuticals, Inc.
Weight: 2.87% Shares: 690 Value: $560.47K
BIIB
Biogen Inc.
Weight: 2.86% Shares: 2.99K Value: $558.49K
GSK
GSK plc
Weight: 2.79% Shares: 10.79K Value: $546.29K
BEAM
Beam Therapeutics Inc.
Weight: 1.36% Shares: 9.19K Value: $265.98K
VNDA
Vanda Pharmaceuticals Inc.
Weight: 1.08% Shares: 24.82K Value: $212.00K
GALT
Galectin Therapeutics Inc.
Weight: 0.93% Shares: 51.48K Value: $182.25K
NTLA
Intellia Therapeutics, Inc.
Weight: 0.71% Shares: 13.79K Value: $139.71K